Ligand Pharmaceuticals Insider Trades
NASDAQ: LGNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 69 · $26.12M
- Shares bought / sold
- 0 / 95.82K
- Net activity
- Net selling $26.1 million
Ligand Pharmaceuticals insider activity
Over the last 12 months, Ligand Pharmaceuticals insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 69 sales. Insiders bought $0 and sold $26.1 million worth of stock, for net insider selling of $26.1 million. The largest seller was Reardon Andrew, with $9.3 million in reported sales.
The most recent filing shows Reardon Andrew (CLO & Secretary) reporting a transaction in 340 shares at $52.27 on Oct 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put LGND's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
LGND insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 2, 2026 | Reardon AndrewCLO & Secretary | Sale | 17 | $5.23K | Form 4 |
| Oct 2, 2026 | Reardon AndrewCLO & Secretary | Sale | 235 | $72.19K | Form 4 |
| Oct 2, 2026 | Reardon AndrewCLO & Secretary | Sale | 404 | $123.70K | Form 4 |
| Oct 2, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,535 | $467.43K | Form 4 |
| Oct 2, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,976 | $599.80K | Form 4 |
| Oct 2, 2026 | Reardon AndrewCLO & Secretary | Sale | 833 | $251.99K | Form 4 |
| Oct 2, 2026 | Reardon AndrewCLO & Secretary | Option exercise | 340 | $17.77K | Form 4 |
| Sep 22, 2026 | Zimmermann MartineDirector | Tax withholding | 115 | $34.33K | Form 4 |
| Sep 10, 2026 | Zimmermann MartineDirector | Sale | 1,200 | $342.00K | Form 4 |
| Sep 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 400 | $115.59K | Form 4 |
| Sep 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 385 | $110.70K | Form 4 |
| Sep 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 2,115 | $605.65K | Form 4 |
| Sep 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,800 | $513.30K | Form 4 |
| Sep 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 300 | $85.20K | Form 4 |
| Aug 12, 2026 | Espinoza OctavioChief Financial Officer | Sale | 31,641 | $9.24M | Form 4 |
| Aug 12, 2026 | Espinoza OctavioChief Financial Officer | Option exercise | 3,348 | $230.14K | Form 4 |
| Aug 12, 2026 | Espinoza OctavioChief Financial Officer | Option exercise | 7,171 | $410.32K | Form 4 |
| Aug 12, 2026 | Espinoza OctavioChief Financial Officer | Option exercise | 2,869 | $159.95K | Form 4 |
| Aug 12, 2026 | Espinoza OctavioChief Financial Officer | Option exercise | 2,074 | $145.26K | Form 4 |
| Aug 12, 2026 | Espinoza OctavioChief Financial Officer | Option exercise | 16,179 | $854.90K | Form 4 |
| Aug 12, 2026 | Haas JasonDirector | Sale | 7,138 | $2.09M | Form 4 |
| Aug 12, 2026 | Haas JasonDirector | Option exercise | 6,138 | $316.48K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 409 | $119.76K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 991 | $289.09K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 200 | $58.12K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 503 | $145.77K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 356 | $102.79K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,214 | $349.36K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,032 | $295.97K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 157 | $44.86K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 33 | $9.39K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Sale | 105 | $29.83K | Form 4 |
| Aug 3, 2026 | Reardon AndrewCLO & Secretary | Option exercise | 5,000 | $261.35K | Form 4 |
| Jul 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 600 | $190.29K | Form 4 |
| Jul 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 900 | $284.20K | Form 4 |
| Jul 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 100 | $31.46K | Form 4 |
| Jul 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 700 | $219.42K | Form 4 |
| Jul 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,081 | $337.57K | Form 4 |
| Jul 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,119 | $348.81K | Form 4 |
| Jul 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 104 | $32.26K | Form 4 |
| Jul 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 396 | $122.36K | Form 4 |
| Jul 1, 2026 | Reardon AndrewCLO & Secretary | Option exercise | 5,000 | $261.35K | Form 4 |
| Jun 30, 2026 | Davis Todd CChief Executive Officer | other | 132 | $21.21K | Form 4 |
| Jun 30, 2026 | Espinoza OctavioChief Financial Officer | other | 17 | $2.73K | Form 4 |
| Jun 30, 2026 | Reardon AndrewCLO & Secretary | other | 132 | $21.21K | Form 4 |
| Jun 16, 2026 | Sabba Stephen LDirector | Sale | 2,145 | $544.83K | Form 4 |
| Jun 16, 2026 | Sabba Stephen LDirector | Option exercise | 2,145 | $141.85K | Form 4 |
| Jun 12, 2026 | Haas JasonDirector | Sale | 3,461 | $886.29K | Form 4 |
| Jun 12, 2026 | Haas JasonDirector | Sale | 3,000 | $765.03K | Form 4 |
| Jun 12, 2026 | Haas JasonDirector | Option exercise | 1,000 | $51.56K | Form 4 |
| Jun 12, 2026 | Haas JasonDirector | Option exercise | 3,000 | $154.68K | Form 4 |
| Jun 11, 2026 | Aryeh JasonDirector | Sale | 4,500 | $1.13M | Form 4 |
| Jun 10, 2026 | Aryeh JasonDirector | Sale | 500 | $125.00K | Form 4 |
| Jun 10, 2026 | LAMATTINA JOHN LDirector | Sale | 3,405 | $856.75K | Form 4 |
| Jun 10, 2026 | LAMATTINA JOHN LDirector | Sale | 697 | $173.92K | Form 4 |
| Jun 10, 2026 | LAMATTINA JOHN LDirector | Sale | 232 | $57.56K | Form 4 |
| Jun 10, 2026 | LAMATTINA JOHN LDirector | Sale | 257 | $63.54K | Form 4 |
| Jun 5, 2026 | Haas JasonDirector | Award | 836 | — | Form 4 |
| Jun 5, 2026 | Gray Nancy RyanDirector | Award | 836 | — | Form 4 |
| Jun 5, 2026 | LAMATTINA JOHN LDirector | Award | 836 | — | Form 4 |
| Jun 5, 2026 | Zimmermann MartineDirector | Tax withholding | 182 | $43.13K | Form 4 |
| Jun 5, 2026 | Zimmermann MartineDirector | Award | 836 | — | Form 4 |
| Jun 5, 2026 | KOZARICH JOHN WDirector | Award | 836 | — | Form 4 |
| Jun 5, 2026 | Sabba Stephen LDirector | Award | 836 | — | Form 4 |
| Jun 5, 2026 | Aryeh JasonDirector | Award | 836 | — | Form 4 |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 200 | $46.08K | Form 4 |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,216 | $279.03K | Form 4 |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 584 | $133.49K | Form 4 |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 400 | $90.71K | Form 4 |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,432 | $323.59K | Form 4 |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 677 | $152.46K | Form 4 |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 491 | $109.96K | Form 4 |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary | Option exercise | 5,000 | $261.35K | Form 4 |
| May 27, 2026 | Espinoza OctavioChief Financial Officer | Option exercise | 972 | $51.36K | Form 4 |
| May 27, 2026 | Espinoza OctavioChief Financial Officer | Option exercise | 764 | $48.61K | Form 4 |
| May 13, 2026 | KOZARICH JOHN WDirector | Sale | 1,575 | $352.01K | Form 4 |
| May 13, 2026 | KOZARICH JOHN WDirector | Option exercise | 1,575 | $109.48K | Form 4 |
| May 12, 2026 | KOZARICH JOHN WDirector | Sale | 459 | $102.82K | Form 4 |
| May 12, 2026 | KOZARICH JOHN WDirector | Option exercise | 459 | $31.91K | Form 4 |
| May 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 800 | $187.21K | Form 4 |
| May 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,420 | $330.75K | Form 4 |
| May 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 780 | $180.99K | Form 4 |
| May 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 370 | $85.42K | Form 4 |
| May 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 98 | $22.51K | Form 4 |
| May 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 932 | $213.20K | Form 4 |
| May 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 600 | $136.47K | Form 4 |
| May 1, 2026 | Reardon AndrewCLO & Secretary | Option exercise | 5,000 | $261.35K | Form 4 |
| May 1, 2026 | KOZARICH JOHN WDirector | Sale | 116 | $27.15K | Form 4 |
| May 1, 2026 | KOZARICH JOHN WDirector | Sale | 105 | $24.42K | Form 4 |
| May 1, 2026 | KOZARICH JOHN WDirector | Sale | 165 | $38.26K | Form 4 |
| May 1, 2026 | KOZARICH JOHN WDirector | Sale | 1 | $229.87 | Form 4 |
| May 1, 2026 | KOZARICH JOHN WDirector | Sale | 80 | $18.19K | Form 4 |
| Apr 1, 2026 | KOZARICH JOHN WDirector | Sale | 146 | $29.20K | Form 4 |
| Apr 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 337 | $68.92K | Form 4 |
| Apr 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 963 | $195.70K | Form 4 |
| Apr 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 700 | $141.33K | Form 4 |
| Apr 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,238 | $248.77K | Form 4 |
| Apr 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 1,302 | $260.04K | Form 4 |
| Apr 1, 2026 | Reardon AndrewCLO & Secretary | Sale | 460 | $91.47K | Form 4 |
| Apr 1, 2026 | Reardon AndrewCLO & Secretary | Option exercise | 5,000 | $261.35K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4